|
⚲
|
| Keyboard |
| Kanfer Jordan
✚
|
|
|---|---|
| CIK # | 0001772350 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001772350] | |
| 4 | [0001772350] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kinex Pharmaceuticals LLC | |
| Kanfer Jordan |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kinex Pharmaceuticals LLC ATNX
Restricted Stock Units · derivative
|
2022-08-03 | Option exercise | 7,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2022-08-03 | Option exercise | 7,500 | ||
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2022-06-28 | Grant | 17,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2021-11-17 | Buy | 4,952 | $2.02 | 10,003 |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2021-08-03 | Grant | 7,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Restricted Stock Units · derivative
|
2021-08-03 | Grant | 7,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2020-09-10 | Buy | 450 | $11.49 | 5,170 |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2020-06-05 | Grant | 15,000 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Common Stock
|
2019-06-06 | Buy | 2,500 | $15.01 | 37,525 |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2019-04-03 | Grant | 2,500 | $0.00 | |
|
Kinex Pharmaceuticals LLC ATNX
Stock Option (Right to Buy) · derivative
|
2019-04-01 | Grant | 10,000 | $0.00 |